Before We Start
Four viruses, four different mechanisms
It's tempting to memorize oncogenic viruses as a simple list — this virus causes that cancer. But the more useful and more commonly tested knowledge is HOW each one causes cancer, since the mechanisms are genuinely different: some directly disable tumor suppressor proteins, some cause a specific chromosomal rearrangement, and some work indirectly through years of chronic inflammation rather than any single oncogenic protein at all.
💡 Memory Trick
HPV (cervical) works via direct tumor suppressor disruption. EBV (Burkitt's) works via a chromosomal translocation. HBV/HCV (hepatocellular) work via chronic inflammation. HTLV-1 (T-cell leukemia) works via a proliferation-activating protein. Same outcome — cancer — four different roads to get there.
The Key Points
The mechanism behind each virus-cancer pairing
HPV
HPV — E6 degrades p53, E7 inactivates Rb
HPV types 16 and 18 cause cervical and oropharyngeal cancers through two specific viral proteins acting directly on the cell's own tumor suppressor machinery: E6 degrades the p53 tumor suppressor protein, and E7 inactivates the Rb tumor suppressor protein. With both of the cell's key safeguards against uncontrolled division disabled simultaneously, cancer-causing mutations can accumulate largely unchecked. The Gardasil vaccine prevents infection with HPV types 16, 18, 6, and 11.
🦠 HPV's E6 protein specifically targets and degrades p53, removing one of the cell's key safeguards against uncontrolled division — a direct molecular mechanism, not an indirect or inflammation-driven one.
EBV
EBV — a c-myc translocation, driving multiple cancer types
EBV causes Burkitt's lymphoma through a specific chromosomal translocation involving the c-myc gene, disrupting normal cell growth regulation. EBV is also linked to Hodgkin's lymphoma and nasopharyngeal carcinoma, making it a virus associated with several genuinely distinct cancer types, not just one.
🦠 EBV-driven Burkitt's lymphoma arises specifically from a c-myc translocation that disrupts normal cell growth regulation — a genetic rearrangement, distinct from HPV's direct tumor-suppressor-disabling mechanism.
HBV/HCV
HBV/HCV — chronic inflammation drives hepatocellular carcinoma
HBV and HCV cause hepatocellular carcinoma (HCC) through a meaningfully different mechanism than HPV or EBV: chronic inflammation and cirrhosis, built up over years of persistent infection, rather than a specific oncogenic viral protein directly disabling tumor suppressors or causing a translocation. The cancer risk here is a slow, indirect consequence of prolonged liver damage rather than a single molecular event.
🦠 A patient with long-standing chronic HCV infection developing cirrhosis over years faces a substantially raised risk of eventually developing hepatocellular carcinoma — the mechanism is cumulative liver damage, not a direct oncogenic protein.
HTLV-1/KSHV
HTLV-1 and KSHV — proliferation activation and opportunistic cancer
HTLV-1's Tax protein directly activates cellular proliferation pathways, causing adult T-cell leukemia/lymphoma — yet another distinct mechanism from the three above. KSHV (also known as HHV-8) causes Kaposi sarcoma, particularly in AIDS patients, reflecting its opportunistic behavior in severely immunocompromised hosts rather than a straightforward oncogenic mechanism in the general population.
🦠 Kaposi sarcoma appearing in an AIDS patient with a severely weakened immune system reflects KSHV's opportunistic oncogenic behavior — it rarely causes cancer in immunocompetent hosts, unlike HPV or EBV.
🏥 Applied Scenario
A patient with long-standing chronic hepatitis C infection develops cirrhosis and is later diagnosed with hepatocellular carcinoma.
Step 1
Ask whether this matches HPV's mechanism: Does HCV cause cancer through the same mechanism as HPV — directly disabling tumor suppressor proteins? No — HBV/HCV instead drive carcinogenesis through chronic inflammation and cirrhosis accumulated over time, a genuinely different mechanism than HPV's direct E6/E7 tumor suppressor disruption.
Step 2
Contrast with a different virus-cancer pairing: If the same patient instead had cervical cancer linked to HPV 16 infection, the mechanism would specifically involve E6 degrading p53 and E7 inactivating Rb — direct molecular disruption of tumor suppressor pathways, not years of chronic inflammation.
Step 3
Recognize the deeper point: Understanding that different oncogenic viruses cause cancer through genuinely different mechanisms — direct tumor suppressor disruption, chromosomal translocation, chronic inflammation, or proliferation activation — is the real content here, beyond simply memorizing which virus causes which cancer.
Step 4
Conclusion: The same end result (cancer) can arise from mechanistically unrelated starting points, which is exactly why exam questions tend to probe mechanism rather than just the virus-cancer pairing itself.
📌 Exam Application
Exams test whether you can match each oncogenic virus (HPV, EBV, HBV/HCV, HTLV-1, KSHV) to its associated cancer type AND its specific mechanism (tumor suppressor disruption, chromosomal translocation, chronic inflammation, or proliferation activation) — not just a simple virus-to-cancer pairing. Expect questions that describe a mechanism and ask which virus it belongs to, rather than simply naming the virus and asking for the cancer.
⚠️ The Trap — Assuming All Oncogenic Viruses Cause Cancer the Same Way
The most common trap is assuming all oncogenic viruses cause cancer through the same general mechanism, simply because they're grouped together under one topic. HPV directly disables tumor suppressors (E6/E7), EBV causes a specific chromosomal translocation (c-myc), HBV/HCV work through chronic inflammation and cirrhosis rather than any direct oncogenic protein, and HTLV-1's Tax protein directly activates proliferation — these are genuinely distinct mechanisms, and exam questions frequently test the mechanism specifically, not just the virus-cancer pairing.
✓ Quick Self-Test
Answer before checking:
1. What do HPV's E6 and E7 proteins do?
2. What vaccine prevents HPV-related cancers, and which HPV types does it cover?
3. What genetic event does EBV cause in Burkitt's lymphoma?
4. Through what mechanism do HBV and HCV cause hepatocellular carcinoma?
5. What cancer does KSHV (HHV-8) cause, and in what population is it particularly notable?
Answers:
1. E6 degrades the p53 tumor suppressor; E7 inactivates the Rb tumor suppressor.
2. Gardasil; it prevents HPV types 16, 18, 6, and 11.
3. A c-myc translocation.
4. Chronic inflammation and cirrhosis, built up over years, rather than a direct oncogenic viral protein.
5. Kaposi sarcoma, particularly notable in AIDS patients.